Search

Search Constraints

You searched for: Author/Creator Gernone, Angela

Search Results

1. Dexamethasone‐Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High‐Dose Cisplatin: A Randomized Noninferiority Study. (18th June 2021)

2. Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. (October 2014)

3. Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. (October 2014)

4. Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting. (October 2014)

5. Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. (May 2014)

6. Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. (May 2014)

7. Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer. (May 2014)

8. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

9. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)

10. Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients. (March 2015)